bovin
rotaviru
brv
import
caus
diarrhea
newborn
calv
local
passiv
immun
effici
protect
strategi
control
diseas
igi
technolog
use
chicken
egg
yolk
immunoglobulin
econom
practic
altern
prevent
brv
diarrhea
dairi
calv
aim
studi
evalu
protect
immunomodul
induc
oral
administr
egg
yolk
enrich
brv
specif
igi
experiment
brv
infect
calv
calv
group
gp
receiv
control
colostrum
cc
brv
viru
neutral
ab
titer
elisa
brv
igg
prior
gut
closur
gut
closur
calv
receiv
milk
supplement
brvimmun
egg
yolk
elisa
igi
ab
titer
nonimmun
control
egg
yolk
vn
elisa
igi
ab
titer
twice
day
day
calv
receiv
cc
colostrum
depriv
calv
cd
fed
antibodi
ab
free
milk
serv
control
gp
respect
calv
inocul
focu
form
unit
ffu
virul
brv
ind
day
age
control
calv
gp
calv
fed
control
igi
gp
infect
develop
sever
diarrhea
around
calv
gp
igi
infect
show
protect
brv
diarrhea
bovin
rvspecif
igi
ab
detect
fece
calv
gp
indic
avian
antibodi
ab
remain
intact
passag
gastrointestin
tract
post
infect
day
duodenum
major
site
brv
specif
antibodi
secret
cell
asc
experiment
group
mucos
asc
respons
isotyp
significantli
higher
igi
treat
group
independ
specif
treatment
indic
egg
yolk
compon
modul
immun
respons
brv
infect
mucos
level
result
indic
supplement
newborn
calv
diet
first
day
life
egg
yolk
enrich
brvspecif
igi
repres
promis
strategi
prevent
brv
diarrhea
moreov
strong
activ
asc
immun
respons
induc
intestin
mucosa
follow
brv
infect
administr
egg
yolk
regardless
specif
treatment
rotavirus
rv
respons
global
signific
gastrointestin
diseas
primarili
children
year
age
young
mammalian
avian
speci
includ
calv
pig
south
american
camelid
parreno
et
al
ramig
saif
lj
diarrhea
commonli
report
newborn
calf
diseas
main
caus
mortal
bendali
et
al
bovin
rotaviru
brv
common
pathogen
involv
neonat
diarrhea
dairi
beef
herd
da
costa
mend
et
al
garaicoechea
et
al
calv
suscept
brv
diarrhea
week
age
third
week
life
suscept
decreas
age
increas
bridger
dhama
et
al
argentina
brv
main
caus
neonat
diarrhea
calv
detect
calf
diarrhea
case
beef
dairi
herd
tenyearsurvey
garaicoechea
et
al
brv
diarrhea
result
greater
financi
loss
cattl
produc
infecti
diseas
particularli
due
reduct
weight
gain
affect
anim
treatment
expens
aich
et
al
bellinzoni
et
al
bendali
et
al
specif
treatment
brv
diarrhea
affect
anim
reciev
therapi
replac
lost
fluid
electrolyt
antibiot
secondari
bacteri
infect
current
strategi
control
diseas
base
vaccin
mother
protect
offspr
transfer
passiv
ab
bellinzoni
et
al
fernandez
et
al
saif
et
al
strategi
reduc
sever
diarrhea
prevent
viru
infect
appear
clinic
sign
bendali
et
al
parreno
et
al
et
al
thorough
understand
mechan
intestin
immun
correl
protect
neonat
critic
develop
effect
vaccin
complementari
altern
passiv
immun
strategi
passiv
immun
oral
administr
specif
ab
differ
sourc
immun
colostrum
chicken
egg
yolk
igi
could
repres
effect
econom
strategi
prevent
gastrointestin
infect
food
anim
rotaviru
preferenti
infect
matur
enterocyt
upper
small
intestin
near
tip
villi
sever
local
intestin
infect
vari
among
anim
speci
studi
howev
patholog
chang
primarili
limit
proxim
small
intestin
candi
dhama
et
al
est
varshney
et
al
consid
earli
suscept
infect
presenc
matern
ab
igg
iga
deriv
unabsorb
colostrum
milk
gut
lumen
play
import
role
protect
brv
infect
diseas
fernandez
et
al
boost
matern
ab
titer
cow
immun
parenter
brv
vaccin
day
calv
dhama
et
al
saif
fernandez
high
titer
passiv
circul
ab
newborn
calv
play
complementari
role
protect
brv
induc
diarrhea
igg
acquir
colostrum
also
transfer
serum
intestin
neonat
calv
besser
et
al
viru
neutral
vn
ab
titer
brv
newborn
calf
serum
may
also
indic
protect
brv
diarrhea
howev
observ
newborn
calv
frequent
develop
brv
diarrhea
despit
moder
high
level
circul
brv
ab
deriv
colostrum
third
week
life
expos
brv
field
est
kohara
tsunemitsu
parreno
et
al
although
serum
ab
essenti
dairi
calv
usual
separ
dam
colostrum
intak
subsequ
fed
milk
replac
lack
ab
previous
demonstr
brv
specif
circul
ab
deriv
colostrum
intak
suppress
develop
brvspecif
ab
secret
cell
asc
respons
neonat
calv
dose
depend
manner
system
mucos
level
parreno
et
al
follow
line
research
second
studi
also
demonstr
administr
milk
supplement
brv
immun
colostrum
first
day
life
induc
high
protect
rate
brv
diarrhea
calv
posit
modul
neonat
immun
respons
toward
higher
number
brvspecif
iga
asc
greater
asc
isotyp
divers
intestin
mucosa
also
shown
activ
immun
respons
protect
brv
challeng
cessat
passiv
ab
supplement
et
al
regard
promis
econom
feasibl
practic
new
strategi
explor
past
two
decad
supplement
milk
diet
calv
specif
ab
egg
yolk
igi
ikemori
et
al
ikemori
et
al
kuroki
et
al
kuroki
et
al
mine
kovacsnolan
bovin
rv
highli
immunogen
poultri
igi
technolog
offer
sever
advantag
classic
way
ab
product
noninvas
technolog
sinc
ab
obtain
collect
egg
thu
anim
need
bled
igi
technolog
align
principl
anim
welfar
reduct
refin
replac
laboratori
anim
ab
isotyp
present
chicken
egg
yolk
igi
isol
igi
ab
simpl
approxim
mg
igi
harvest
month
lay
hen
mgegg
yolk
antigen
specif
igi
repres
faster
cheaper
way
polyclon
ab
product
sourc
regard
function
four
import
differ
avian
igi
mammalian
igg
igi
bind
protein
g
rheumathoid
factor
chicken
egg
yolk
immunoglobulin
interfer
mammalian
igg
serolog
test
activ
mammalian
complement
differ
advantag
applic
igi
technolog
mani
area
diagnost
altern
antibiot
therapi
carland
et
al
schade
et
al
tini
et
al
passiv
protect
newborn
calv
group
brv
use
specif
egg
yolk
immunoglobulin
milk
supplement
within
immedi
postnat
period
may
suitabl
clinic
option
control
brv
diarrhea
demonstr
previous
treatment
brv
diarrhea
use
avian
egg
yolk
enrich
brv
specif
igi
ab
first
week
life
enhanc
bodi
weight
gain
markedli
reduc
brv
infect
viru
titer
stool
well
number
calv
shed
viru
heckert
et
al
kuroki
et
al
touchett
et
al
indic
egg
yolk
ab
potenti
tool
brv
infect
administ
daili
immedi
birth
brv
incid
higher
howev
inform
heterolog
ab
egg
yolk
may
modul
mucos
system
immun
respons
newborn
calv
brv
critic
develop
activ
immun
futur
viral
exposur
object
studi
evalu
administr
milk
enrich
brv
specif
avian
igi
ab
first
day
life
suitabl
prevent
strategi
protect
calv
brv
diarrhea
entir
period
suscept
diseas
without
inhibit
develop
activ
immun
respons
studi
newborn
calv
receiv
pool
colostrum
nonimmun
dam
control
colostrum
cc
previou
gut
closur
within
first
hour
life
studi
protect
modulatori
effect
chicken
egg
yolk
ab
calv
fed
gut
closur
h
life
day
commerci
abfre
milk
supplement
crude
egg
yolk
hen
hyperimmun
brv
better
understand
modulatori
effect
local
passiv
heterolog
ab
induct
activ
system
mucos
immun
respons
brv
infect
improv
applic
strategi
prevent
brv
diarrhea
dairi
calv
anim
includ
human
infant
colostrum
feed
calf
inoculationtwentyeight
newborn
holstein
male
calv
procur
dairi
farm
remov
mother
birth
prior
suckl
move
isol
facil
within
first
hour
life
anim
hous
individu
isol
room
strict
manag
protocol
previous
describ
parreno
et
al
protocol
anim
manag
euthanasia
met
requir
institut
anim
care
committe
iacc
veterinari
colleg
univers
bueno
air
offic
laboratori
anim
welfar
olaw
nih
calv
group
gp
receiv
l
control
colostrum
cc
within
first
hour
life
previou
gut
closur
colostrum
viru
neutral
ab
vn
titer
brv
brv
igg
ab
titer
determin
elisa
tabl
anim
group
reach
circul
brv
igg
ab
titer
serum
calv
gp
colostrum
depriv
cd
receiv
l
ab
free
milk
time
point
thereaft
first
h
life
ab
free
milk
given
anim
l
period
time
anim
assign
passiv
treament
group
gp
start
treatment
period
time
assur
administr
heterolog
ab
start
gut
closur
stott
fellah
calv
randomli
assign
one
follow
feed
group
gp
cc
milk
supplement
brvspecif
egg
yolk
final
brv
igi
ab
titer
gp
cc
milk
supplement
normal
egg
yolk
final
brv
igi
ab
titer
igi
ab
titer
milk
determin
elisa
two
group
calv
neg
control
one
receiv
one
dose
cc
gp
other
colostrum
depriv
cd
calv
gp
thereaft
fed
milk
without
brv
ab
gonzalez
et
al
calv
gp
fed
twice
day
l
supplement
milk
day
onward
calv
group
fed
milk
without
supplement
ab
milk
use
experi
commerci
steril
bovin
milk
human
consumpt
mastellon
hno
bs
argentina
tabl
anim
oral
inocul
focu
form
unit
ffu
virul
indiana
ind
p
brv
third
fourth
feed
approxim
hour
colostrum
intak
postinocul
day
pid
viral
dose
previous
confirm
caus
diarrhea
viru
shed
inocul
cd
calv
parreno
et
al
calv
euthan
pid
studi
primari
ab
respons
brv
infect
examin
daili
develop
diarrhea
viru
shed
brv
inocul
presenc
elev
rectal
temperatur
record
estim
sever
diarrhea
fecal
consist
score
follow
normal
pasti
semiliquid
liquid
score
equal
greater
consid
diarrhea
score
done
blindli
qualifi
technician
prior
brv
inocul
fecal
sampl
collect
daili
assess
viru
shed
serum
sampl
collect
colostrum
feed
within
hour
birth
inocul
weekli
pid
serum
ab
brv
detect
elisa
vn
assay
presenc
coproantibodi
assess
elisa
peripher
blood
lymphocyt
pbl
sampl
pid
weekli
assess
asc
respons
elispot
assay
bodi
weight
measur
pid
weekli
pid
anim
euthan
number
brv
asc
also
quantifi
elispot
follow
mucosalassoci
lymphoid
tissu
malt
duodenum
jejunum
ileum
lamina
propria
lp
jejunum
ileum
peyer
patch
pp
jejunum
cecal
mesenter
lymph
node
mln
system
lymphoid
tissu
spleen
pbl
larg
lic
small
sic
intestin
content
calv
collect
necropsi
ab
detect
elisa
parreno
et
al
consist
intestin
content
cd
calf
oral
inocul
fecal
suspens
contain
virul
brv
describ
previous
fernandez
et
al
parreno
et
al
cellcultureadapt
ind
brv
propag
monkey
kidney
cell
use
elispot
elisa
vn
assay
parreno
et
al
et
al
control
colostrum
pool
use
studi
initi
colostrum
intak
experiment
calv
gp
deriv
nonvaccin
brv
seroposit
dairi
cow
prepar
laboratori
describ
previous
store
use
igg
ab
titer
brv
determin
elisa
vn
ab
titer
et
al
egg
yolk
pool
use
studi
obtain
immun
nonimmun
hen
lohmann
brown
classic
lay
hen
hous
cage
special
design
built
purpos
group
two
anim
per
cage
follow
anim
welfar
recommend
schade
hlinak
room
temperatur
rel
humid
lightdark
cycl
control
hen
fed
lay
hen
diet
water
ad
libitum
egg
collect
daili
start
first
immun
live
attenu
ind
brv
p
contain
ffuml
mix
ratio
freund
complet
adjuv
fca
freund
incomplet
adjuv
fia
sigmaaldrich
bird
immun
intramuscularli
breast
immunogen
fca
use
first
immun
fia
use
subsequ
booster
inject
egg
yolk
immun
hen
dilut
distil
water
ratio
pool
prepar
weekli
store
brv
igi
ab
titer
determin
ind
brv
elisa
vn
assay
pool
high
brv
igi
ab
titer
maintain
brv
igi
pool
egg
yolk
nonimmun
hen
process
similar
manner
control
igi
pool
tabl
ab
titer
need
milk
diet
neonat
calv
protect
diarrhea
supplement
milk
prepar
addit
crude
liquid
egg
yolk
previous
frozen
pool
two
immun
milk
contain
final
igi
ab
titer
brv
determin
elisa
initi
test
pilot
studi
calv
fed
milk
final
igi
ab
titer
protect
diarrhea
viru
shed
data
shown
supplement
milk
final
igi
ab
titer
prevent
brv
induc
diarrhea
calv
henc
present
studi
specif
address
potenti
interfer
effect
local
passiv
heterolog
ab
treatment
test
supplement
milk
induc
high
protect
diarrhea
viru
shed
brv
igi
final
ab
titer
milk
supplement
control
egg
yolk
brv
igi
final
ab
titer
compar
colostrum
depriv
calv
cd
calv
receiv
control
colostrum
cc
fed
milk
without
ab
titer
vn
isotyp
specif
ab
ind
brv
determin
elisa
bovin
colostrum
egg
yolk
pool
egg
yolk
supplement
milk
use
feed
calv
summar
tabl
main
isotyp
present
colostrum
igg
igi
primari
ab
isotyp
present
egg
yolk
pool
supplement
milk
milk
use
feed
calv
assign
gp
gp
prepar
ad
ml
egg
yolk
pool
brv
igi
pool
control
igi
pool
respect
l
commerci
steril
milk
volum
egg
yolk
ad
milk
repres
total
feed
volum
tabl
addit
brv
igi
pool
milk
gp
confer
final
igi
ab
titer
brv
vn
titer
final
igi
ab
titer
brv
vn
titer
gp
milk
achiev
rotaviru
antigen
detectionrotaviru
shed
detect
fecal
sampl
use
antigen
captur
elisa
describ
previous
cornaglia
em
cell
cultur
immunofluoresc
assay
ccif
viru
infecti
titer
assess
cell
cultur
immunofluoresc
ccif
assay
et
al
fluoresc
foci
visual
use
fitclabel
hyperimmun
bovin
antiserum
ind
brv
fluoresc
fociform
cell
count
use
fluoresc
microscop
titer
express
number
fluoresc
focu
form
unit
per
ml
ffuml
bovin
isotypespecif
antibodi
elisath
igm
iga
igg
ab
titer
ind
brv
quatit
colostrum
pool
calf
sera
fece
lic
sic
specif
igg
ab
detect
indirect
elisa
use
reagent
protocol
describ
previous
fernandez
et
al
parreno
et
al
specif
igm
iga
ab
measur
captur
elisa
standard
laboratori
use
antibovin
igm
mab
kindli
suppli
dr
lj
saif
ohio
state
univers
usa
affin
purifi
sheep
antibovin
iga
polyclon
antibodi
bethyl
laboratori
inc
montgomeri
texa
usa
parreno
et
al
igi
ab
titer
ind
brv
determin
crude
egg
yolk
pool
calf
hen
sera
calf
fece
supplement
milk
indirect
elisa
briefli
well
elisa
plate
maxisorp
nunc
coat
brv
hyperimmun
antiserum
prepar
guinea
pig
block
step
albumin
chicken
egg
white
sigmaaldrich
germani
supernat
cell
cultur
lysat
brvinfect
mockinfect
ad
follow
serial
fourfold
dilut
sampl
reaction
develop
use
peroxidas
label
polyclon
goat
antichicken
igi
ab
sigmaaldrich
germani
conjug
hydrogen
peroxid
abt
susbtratecromogen
system
neutral
vn
ab
titer
ind
brv
colostrum
pool
egg
yolk
pool
supplement
milk
calf
sera
determin
fluoresc
focu
neutral
ffn
test
previous
describ
vn
titer
express
reciproc
highest
sampl
dilut
result
reduct
number
fluoresc
foci
approxim
cm
tissu
sampl
duodenum
jejunum
ileum
lamina
propria
collect
discret
peyer
patch
pp
identifi
differ
point
along
mucos
surfac
jejunum
collect
individu
segment
intestin
correspond
cm
portion
distal
ileum
continu
peyer
patch
also
obtain
mesenter
lymph
node
mln
correspond
jejunum
ileocec
region
collect
process
separ
intestin
tissu
initi
digest
dithiotreithol
gibco
brl
grand
island
ny
usa
collagenas
type
ii
sigma
chemic
co
st
loui
mo
usa
mnc
suspens
obtain
centrifug
consecut
percol
densiti
gradient
amersham
pharmacia
biotech
uppsala
sweden
previous
describ
pig
tissu
yuan
et
al
mononuclear
cell
blood
spleen
extract
evalu
asc
respons
system
lymphoid
tissu
tissu
pass
stainless
steel
screen
cell
collector
cellector
ec
apparatu
corp
petersburg
fl
usa
mononuclear
cell
blood
isol
ficollpaqu
amersham
bioscienc
uppsala
sweden
densiti
gradient
centrifug
follow
recommend
manufactur
puri
ed
mnc
tissu
resuspend
nal
concentr
mncml
gibco
brl
grand
island
ny
usa
supplement
fc
mm
hepe
mm
glutamin
mm
sodium
pyruv
mm
nonessenti
aminoacid
iuml
penicillin
mgml
streptomycin
mgml
gentamycin
erpmi
cell
viabil
mnc
suspens
assess
trypan
blue
exclus
case
elispot
assay
brvspecif
ascan
elispot
assay
quantif
antibrv
igm
iga
igg
igg
asc
conduct
evalu
effector
bcell
respons
calv
pid
previous
describ
parreno
et
al
briefli
ind
brv
infect
cell
plate
fix
aceton
air
dri
store
use
mononuclear
cell
differ
tissu
count
use
trypan
blue
stain
three
dilut
singlecel
suspens
per
tissu
plate
cellswel
plate
incub
hour
co
plate
incub
set
commerci
peroxidaselabel
goat
polyclon
ab
bovin
igm
igg
igg
iga
bethyl
laboratori
inc
montgomeri
texa
usa
h
spot
develop
tetramethylbenzidin
peroxidas
substrat
system
tmb
kpl
gaithersburg
md
usa
fisher
exact
test
use
compar
proport
calv
diarrhea
viru
shed
among
group
kruskallw
rank
sum
nonparametr
test
use
compar
day
onset
durat
diarrhea
viru
shed
cumul
diarrhea
score
cumul
titer
viru
shed
day
high
rectal
temperatur
among
group
neutral
isotypespecif
ab
titer
log
transform
prior
statist
analysi
differ
ab
titer
among
group
evalu
gener
analysi
varianc
anova
follow
dgc
multipl
comparison
test
repeat
measur
throughout
time
neg
sampl
dilut
assign
arbitrari
ab
titer
calcul
geometr
mean
titer
gmt
pid
asc
number
compar
among
group
use
kruskallw
rank
sum
test
statist
signific
assess
p
comparison
differ
among
bodi
weight
gain
analyz
student
test
statist
analys
conduct
use
statistix
analyt
softwar
tallahase
usa
version
statist
softwar
result
variou
paramet
associ
brv
infect
diseas
summar
tabl
inocul
brv
calv
fed
milk
supplement
brv
immun
egg
yolk
day
brv
igi
gp
protect
diarrhea
one
anim
complet
protect
infect
diseas
three
anim
shed
viru
asymptomat
one
calf
develop
mild
diarrhea
day
inocul
day
tabl
figur
onset
clinic
sign
calf
slightli
delay
durat
sever
ill
significantli
diminish
compar
group
anim
receiv
passiv
ab
treatment
gp
gp
tabl
addit
calf
show
signific
reduct
number
day
high
temperatur
associ
diarrhea
day
comparison
group
gp
gp
respect
tabl
hand
calv
receiv
milk
supplement
igi
deriv
nonimmun
hen
gp
develop
diarrhea
tabl
howev
sever
diseas
term
diarrhea
score
day
elev
temperatur
significantli
reduc
shorter
durat
compar
calv
receiv
control
colostrum
gp
cd
calv
gp
fed
ab
free
milk
tabl
compar
gp
igi
sever
mean
durat
diarrhea
number
day
fever
gp
control
igi
higher
significantli
tabl
regard
brv
infect
gp
calv
igi
shed
viru
oral
inocul
mean
durat
titer
similar
control
group
gp
tabl
specif
one
anim
shed
detect
viru
three
calv
shed
viru
asymptomat
one
calf
develop
diarrhea
shed
viru
prolongu
period
day
tabl
figur
brvspecif
igi
detect
fece
gp
calv
beggin
treatment
onset
viru
shed
thereaft
end
treatment
particular
one
calf
shed
viru
reduct
brv
igi
ab
titer
fece
evid
initi
day
inocul
data
shown
suggest
anim
infect
viru
shed
detect
igi
ab
present
gut
calv
fed
milk
supplement
nonspecif
igi
gp
shed
viru
pattern
similar
control
group
gp
cc
gp
cd
howev
mean
titer
viru
shed
gp
calv
significantli
higher
group
compar
gp
igi
mean
brv
titer
fece
control
igi
treat
calv
higher
statist
signific
pattern
viru
shed
cc
cd
calv
gp
respect
character
rapid
onset
calv
cc
ab
free
milk
diet
gp
show
differ
pattern
anim
calv
shed
viru
almost
day
other
day
post
inocul
averag
group
pid
tabl
howev
cd
anim
gp
show
uniform
viru
shed
pattern
faster
resolut
averag
pid
tabl
fig
concern
bodi
weight
gain
calv
fed
milk
supplement
egg
yolk
hyperimmun
hen
gp
significantli
increas
bodi
weight
pid
compar
control
igi
treat
calv
gp
student
test
gp
kg
vs
gp
kg
supplementari
materi
tabl
fig
isotypespecif
vn
ab
respons
ind
brv
serum
number
antibrv
asc
pbl
depict
fig
statist
analysi
detail
supplementari
materi
tabl
colostrum
administr
calv
gp
show
high
igg
ab
vn
ab
titer
brv
sera
fig
b
c
calv
gp
show
significantli
higher
igg
ab
titer
gp
pid
howev
differ
disappear
pid
bovin
rv
igg
vn
titer
remain
high
constant
within
group
supplementari
materi
tabl
detect
high
igg
ab
titer
indic
colostrum
intak
colostrumdepriv
calv
gp
show
strong
immun
respons
brv
develop
igg
vn
ab
brv
serum
titer
similar
detect
experiment
group
pid
increas
number
igg
asc
gp
along
experi
fig
brv
inocul
igm
iga
ab
detect
serum
anim
associ
appear
igm
iga
asc
blood
indic
calv
prime
brv
inocul
without
supplement
igi
ab
milk
pid
cd
calv
gp
show
significantli
higher
igm
higher
iga
ab
titer
calv
receiv
colostrum
gp
supplementari
materi
tabl
asc
respons
blood
number
igm
asc
significantli
higher
calv
without
milk
supplement
gp
gp
calv
fed
milk
supplement
egg
yolk
gp
gp
time
point
similar
profil
lower
magnitud
observ
iga
asc
blood
iga
ab
serum
peak
ab
titer
detect
pid
fig
igg
ab
respons
detect
serum
igg
asc
detect
blood
cd
calv
gp
pid
fig
isotypespecif
ab
respons
ind
brv
fece
evalu
daili
lic
sic
determin
pid
shown
figur
statist
analysi
detail
supplementari
materi
tabl
strong
igg
ab
respons
brv
inocul
detect
cd
group
gp
lower
magnitud
cc
group
gp
fig
pid
cd
calv
gp
show
significantli
higher
igg
ab
fece
experiment
group
supplementari
materi
tabl
brvspecif
igm
iga
respons
detect
pid
titer
high
least
pid
appear
ab
associ
viru
clearanc
calv
receiv
passiv
igi
treatment
clear
viru
shed
faster
calv
fed
ab
free
milk
activ
immun
respons
detect
gp
day
gp
day
gp
day
gp
day
signific
differ
detect
among
group
ab
isotyp
suggest
milk
supplement
affect
activ
immun
respons
brv
although
brv
igi
ab
present
gut
gp
calv
fig
ab
respons
sic
lic
examin
isotyp
pid
calv
gp
control
igi
highest
brv
igm
iga
ab
titer
anim
gp
cc
cd
intermedi
profil
anim
gp
brv
igi
lower
ab
titer
supplementari
materi
tabl
pid
calv
group
igg
ab
intestin
content
highest
titer
cd
calv
howev
differ
observ
statist
signific
pid
calv
euthan
tissu
collect
mononuclear
cell
system
galtassoci
tissu
obtain
test
determin
isotyp
number
distribut
asc
specif
brv
magnitud
profil
brv
asc
respons
evalu
elispot
pbl
spleen
mln
depict
fig
rel
small
number
brv
asc
isotyp
found
pbl
pid
fig
supplementari
materi
tabl
howev
calv
gp
cc
ab
free
milk
significantli
higher
number
igm
iga
asc
calv
gp
brv
igi
control
igi
milk
treatment
respect
spleen
calv
brv
igi
gp
fewer
brv
asc
isotyp
control
group
gp
pid
expect
calv
cc
cd
group
gp
respect
brv
asc
isotyp
particular
igg
predomin
isotyp
gp
iga
igm
asc
abund
gp
calv
fig
collect
result
suggest
trend
toward
reduct
number
brv
asc
system
pbl
spleen
specif
durat
treatment
increas
colostrum
depriv
calv
cd
gp
calv
fed
l
control
colostrum
cc
gp
follow
calv
receiv
colostrum
plu
milk
supplement
egg
yolk
gp
eventhough
possibl
explan
phenomenon
could
increas
viral
antigen
intestin
may
result
greater
system
respons
correl
observ
viru
shed
system
respons
data
shown
egg
yolk
supplement
group
ileocec
mln
develop
strong
asc
respons
brv
infect
abund
asc
isotyp
iga
igg
follow
igg
interestingli
complet
invert
profil
observ
cd
calv
gp
jejun
mln
predomin
isotyp
brv
asc
igg
follow
iga
igm
igg
asc
almost
detect
pid
figur
asc
respons
brv
intestin
mucosa
depict
figur
rotaviru
isotypespecif
asc
detect
lymphoid
tissu
test
pid
asc
present
proxim
intestin
lamina
propria
duodenum
jejunum
lower
magnitud
pp
independ
treatment
find
agreement
site
brv
infect
replic
small
intestin
repres
main
galt
effector
induct
site
respect
asc
respons
brv
duodenum
jejunum
lamina
propria
significantli
higher
egg
yolk
treat
group
gp
gp
ab
free
diet
group
gp
isotyp
test
independ
specif
igi
control
brvspecif
addit
profil
asc
respons
duodenum
calv
fed
milk
supplement
egg
yolk
character
high
number
iga
follow
igg
asc
profil
observ
nontreat
calv
gp
gp
character
domin
iga
follow
igg
asc
brv
igi
group
gp
show
strong
brv
asc
respons
restrict
duodenum
jejunum
lamina
propria
weak
respons
ileum
compar
control
group
gp
calv
receiv
control
egg
yolk
gp
show
strong
immun
respons
duodenum
observ
gp
intermedi
behavior
gp
control
group
gp
jejunum
lamina
propria
region
galt
show
import
differ
regard
number
isotyp
profil
asc
respons
brv
infect
evalu
milk
supplement
igi
ab
crude
egg
yolk
abil
prevent
brv
diarrhea
calv
goal
provid
passiv
ab
gut
prevent
diseas
still
allow
subclin
infect
prime
neonat
mucos
immun
respons
brv
group
calv
fed
milk
supplement
crude
egg
yolk
final
elisa
igi
ab
titer
brv
show
protect
rate
brv
diarrhea
result
indic
treatment
caus
signific
reduct
percentag
affect
anim
durat
sever
ill
brvassoci
high
temperatur
wich
also
coincid
presenc
brv
igi
ab
fece
detect
brv
igi
ab
fece
gp
treat
anim
clearli
demonstr
igi
ab
pass
intestin
tract
remain
biolog
activ
igi
ab
fece
show
similar
kinet
pattern
calv
wherea
decreas
brv
igi
ab
titer
associ
viru
shed
bind
brv
igi
ab
infecti
virion
may
explain
absenc
diarrhea
treatment
although
viru
replic
gut
newborn
calv
contrast
supplement
milk
nonspecif
crude
egg
yolk
gp
control
igi
milk
fail
protect
calv
diarrhea
onset
durat
sever
ill
reduc
gp
compar
cc
cd
calv
gp
respect
eventhough
differ
statist
signific
mean
brv
titer
fece
control
igi
treat
calv
higher
gp
calv
igi
although
crude
egg
yolk
given
passiv
treatment
start
immedi
colostrum
intak
import
condit
experiment
design
administ
first
dose
right
gut
closur
h
post
deliveri
stott
fellah
avoid
egg
yolk
igi
ab
uptak
serum
consequ
igi
ab
detect
serum
sampl
anim
gp
brv
igi
control
igi
respect
thu
system
effect
expect
observ
oral
administr
egg
yolk
addit
econom
egg
possess
mani
characterist
high
qualiti
anim
feed
ingredi
typic
nutrient
analysi
liquid
egg
show
protein
fat
ash
also
valuabl
sourc
iron
phosphor
trace
miner
vitamin
reason
egg
yolk
whole
egg
studi
extens
altern
protein
sourc
anim
feed
promis
result
author
conclud
egg
includ
level
diet
around
total
protein
growth
perform
calv
improv
similar
observ
receiv
ab
free
milk
diet
touchett
et
al
work
supplement
milk
diet
newborn
calv
crude
egg
yolk
gp
gp
calv
fed
milk
supplement
egg
yolk
enrich
igi
ab
brv
gp
show
significantli
increas
mean
bodi
weight
compar
calv
fed
milk
supplement
control
egg
yolk
gp
postbrv
challeng
similar
result
report
kuroki
et
al
calv
field
condit
kuroki
et
al
result
indic
effect
crude
egg
yolk
bodi
weight
gain
improv
presenc
brv
specif
igi
ab
induc
high
protect
rate
brv
diarrhea
salmonella
also
import
pathogen
respons
neonat
diarrhea
calv
bellinzoni
et
al
eventhough
main
bacteri
agent
respons
diarrhea
outbreak
herd
argentina
potenti
biohazard
consid
studi
lay
hen
affect
work
vaccin
salmonella
prevent
contamin
egg
may
result
subsequ
bacteri
infect
calv
treatment
studi
develop
modul
activ
serum
fecal
ab
respons
brv
infect
evalu
brvspecif
asc
respons
system
mucosalassoci
lymphoid
tissu
also
determin
convent
calv
fed
milk
supplement
brv
immun
egg
yolk
although
differ
ab
titer
kinet
found
experiment
group
clear
anim
develop
specif
immun
respons
brv
antibodi
supplement
diet
gp
caus
short
delay
develop
activ
immun
respons
serum
may
relat
milder
clinic
sign
previous
shown
serum
fece
experiment
group
igm
first
isotyp
appear
follow
iga
later
igg
gp
calv
administr
milk
supplement
chicken
egg
yolk
induc
low
system
pbl
spleen
asc
respons
brv
agreement
respons
subclin
infect
similar
result
report
calv
fed
milk
supplement
brvimmun
colostrum
et
al
collect
asc
respons
system
tissu
pbl
spleen
suggest
trend
toward
reduct
number
brv
asc
specif
durat
treatment
increas
colostrum
depriv
calv
cd
gp
calv
fed
l
control
colostrum
cc
gp
follow
calv
receiv
colostrum
plu
milk
supplement
egg
yolk
gp
passiv
treatment
base
administr
milk
supplement
brv
immun
colostrum
newborn
calv
first
day
life
induc
high
protect
rate
diarrhea
posit
modul
neonat
immun
respons
toward
higher
number
iga
asc
greater
isotyp
divers
intestin
mucosa
et
al
unclear
whether
immunomodul
due
ab
presenc
bioactiv
factor
colostrum
sourc
brv
igg
ab
milk
diet
supplement
crude
chicken
egg
yolk
signific
diversif
enhanc
local
immun
respons
brv
observ
duodenum
jejunum
lamina
propria
ileocec
mln
primari
tissu
involv
iga
domin
asc
isotyp
follow
igg
instead
igg
interestingli
effect
independ
specif
treatment
significantli
pronounc
one
observ
previous
calv
receiv
milk
supplement
titer
homolog
bovin
igg
ab
colostrum
et
al
result
agreement
presenc
immunomodul
molecul
egg
yolk
promot
b
cell
clonal
expans
iga
switch
relat
antiinflammatori
respons
dietari
antigen
nelson
unclear
compon
crude
egg
yolk
respons
observ
increas
number
asc
brv
calv
group
mani
possibl
explan
immunomodulatori
properti
crude
egg
yolk
bioactiv
molecul
hormon
cytokin
present
egg
yolk
xu
et
al
describ
immunomodulatori
properti
tranfer
factor
tf
found
egg
yolk
immun
hen
tf
increas
thymusspleen
index
stimul
prolifer
lymphocyt
mice
factor
seem
specif
immun
activ
hepat
b
viru
also
nonspecif
immun
activ
make
potenti
immunoregul
egg
yolk
enhanc
treatment
viral
infect
xu
et
al
nelson
et
al
also
found
egg
yolk
protein
digest
nonimmun
hen
immunomodulatori
activ
gut
vivo
may
act
directli
block
pathogen
entri
indirectli
activ
immun
system
prevent
infect
author
demonstr
egg
yolk
low
lipid
peptid
digest
induc
iga
asc
gut
prevent
limit
adher
colon
enteropathogen
also
egg
yolk
compound
orchestr
respons
induc
secret
potent
activ
b
cell
antiinflamatori
agent
gut
nelson
also
well
known
egg
lysophosphatidylcholin
lpc
possess
adjuv
properti
promot
dendrit
cell
matur
respons
vitro
induc
ab
respons
specif
viral
antigen
administ
system
mice
bach
et
al
perrincocon
et
al
despit
stimulatori
activ
egg
yolk
interest
amplifi
immun
respons
ocur
effector
site
within
first
portion
gut
duodenum
jejun
lamina
propria
mesenter
lymph
node
drain
larg
intestin
ileocec
mln
differ
detect
jejun
pp
ileum
collect
result
indic
practic
feed
crude
egg
yolk
supplement
milk
final
igi
ab
titer
brv
highli
effect
control
brv
diarrhea
endem
dairi
farm
neonat
calf
diarrhea
repres
import
econom
problem
svensson
et
al
administr
milk
supplement
brv
immun
egg
yolk
first
day
life
induc
high
protect
rate
brv
diarrhea
calv
period
peak
suscept
infect
secondli
posit
modul
neonat
immun
respons
includ
higher
number
asc
greater
isotyp
divers
observ
intestin
mucosa
immunomodulatori
effect
egg
yolk
mucos
immun
system
character
may
repres
novel
advantag
igi
technolog
allow
use
prevent
strategi
also
specif
treatment
brv
diarrhea
refer
web
version
pubm
central
supplementari
materi
left
axi
geometr
mean
isotypespecif
neutral
ab
titer
gmt
ind
brv
serum
collect
weekli
line
right
axi
number
brvspecif
mnc
pbl
bar
error
bar
sd
gp
calv
fed
control
colostrum
cc
follow
brv
egg
yolk
supplement
milk
final
brv
igi
ab
titer
b
gp
calv
receiv
cc
follow
control
egg
yolk
supplement
milk
final
brv
igi
ab
titer
c
gp
calv
receiv
cc
gp
colostrum
depriv
calv
fed
abfre
milk
calv
oral
inocul
ind
brv
pid
bar
correspond
asc
isotyp
differ
upper
case
superscript
letter
indic
signific
differ
among
group
isotyp
kruskalw
nonparametr
sum
rank
test
p
statist
analysi
ab
titer
serum
detail
supplementari
materi
tabl
anova
follow
dgc
multipl
comparison
test
time
p
geometr
mean
isotypespecif
ab
titer
gmt
ind
brv
detect
daili
fece
gp
calv
fed
control
colostrum
cc
follow
brv
egg
yolk
supplement
milk
final
brv
igi
ab
titer
b
gp
calv
receiv
cc
follow
control
egg
yolk
supplement
milk
final
brv
igi
ab
titer
c
gp
calv
receiv
cc
gp
colostrum
depriv
calv
fed
abfre
milk
anim
oral
inocul
day
hour
colostrum
intak
day
post
inocul
pid
euthan
pid
sic
small
intestin
content
lic
larg
intestin
content
collect
pid
column
repres
mean
titer
viru
shed
per
day
per
group
ccif
assay
bar
repres
mean
day
diarrhea
durat
group
statist
analysi
ab
titer
fece
analyz
everi
day
detail
supplementari
materi
tabl
anova
follow
dgc
multipl
comparison
test
time
p
mean
number
brv
asc
per
mnc
obtain
system
lymphoid
tissu
pbl
spleen
mln
drain
small
larg
intestin
pid
gp
calv
fed
control
colostrum
cc
follow
brv
egg
yolk
supplement
milk
final
brv
igi
ab
titer
b
gp
calv
receiv
cc
follow
control
egg
yolk
supplement
milk
final
brv
igi
ab
titer
c
gp
calv
receiv
cc
gp
colostrum
depriv
calv
fed
abfre
milk
tissu
compar
mean
asc
number
isotyp
among
treatment
group
bar
differ
letter
indic
signific
differ
kruskalw
rank
sum
test
p
n
number
calv
group
error
bar
indic
sd
mean
number
brv
asc
per
mnc
obtain
intestin
mucosa
associ
lymphoid
tissu
galt
duodenum
jejunum
lp
pp
ileum
lp
pp
pid
gp
calv
fed
control
colostrum
cc
follow
brv
egg
yolk
supplement
milk
final
brv
igi
ab
titer
b
gp
calv
receiv
cc
follow
control
egg
yolk
supplement
milk
final
brv
igi
ab
titer
c
gp
calv
receiv
cc
gp
colostrum
depriv
calv
fed
abfre
milk
tissu
compar
mean
asc
number
isotyp
among
treatment
group
bar
differ
letter
indic
signific
differ
kruskalw
rank
sum
test
p
n
number
calv
group
error
bar
indic
sd
pleas
note
diff
axi
b
diarrhea
durat
defin
number
day
fecal
score
stool
consist
score
daili
c
mean
cumul
score
pid
calcul
measur
sever
diarrhea
sum
daili
fecal
score
n
e
mean
column
differ
superscript
upper
case
letter
differ
significantli
kruskallw
rank
sum
test
p
cc
control
colostrum
cd
colostrum
depriv
calv
fed
liter
milk
twice
day
day
without
addit
correspond
volum
ind
brv
igi
pool
control
igi
pool
accord
group
